OTC · RHEPB
Regional Health Properties, Inc.
$5.80$0.00 (0.0%)
Regional Health Properties, Inc.’s quoted price sits in the lower half of its reported 52-week range, 13.43% below the high.
Loading market information…
OTC · NUMD · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Nu-Med Plus, Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Nu-Med Plus, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Nu-Med Plus, Inc. is a global medical technology firm dedicated to the innovation, refinement, and commercialization of various medical instruments. The company's offerings include a diverse array of nitric oxide delivery systems, such as specialized units for hospital environments, clinical applications, and research settings, alongside a mobile, rechargeable device designed for portable nitric oxide gas administration. Serving a broad spectrum of healthcare entities, its primary clients consist of hospitals, integrated health systems, and the wider medical professional community. Nu-Med Plus, Inc. was founded in 2011 and maintains its corporate headquarters in Salt Lake City, Utah.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:09 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$5.80$0.00 (0.0%)
Regional Health Properties, Inc.’s quoted price sits in the lower half of its reported 52-week range, 13.43% below the high.
$0.01$0.00 (0.0%)
Polarean Imaging plc’s quoted price sits in the upper half of its reported 52-week range, 1.49% below the high.
$2.84$0.00 (0.0%)
Talis Biomedical Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.10$0.00 (0.0%)
Kelyniam Global, Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
$0.31+$0.01 (+3.33%)
QHSLab, Inc.’s quoted price sits in the lower half of its reported 52-week range, 72.81% below the high.
$0.01$0.00 (0.0%)
Reliq Health Technologies Inc.: Healthcare · Medical - Healthcare Information Services.
$0.08+$0.04 (+122.22%)
Costas, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
Cryomass Technologies Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.0% below the high.
